Challenges of empirical antibiotic therapy for community-acquired pneumonia in children

<h4>Background</h4> <p>Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality globally, responsible for more than 14% of deaths in children younger than 5 years of age. Due to difficulties with pathogen identification and diagnostics of CAP in children, t...